Publication Name	World Journal of Clinical Oncology
Manuscript ID	19912
Country	Spain

Received	2015-05-25 14:36
Peer-Review Started	2015-05-27 08:58
To Make the First Decision	2015-07-27 15:48
Return for Revision	2015-08-04 10:09
Revised	2015-08-09 01:50
Second Decision	2015-09-14 10:12
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2015-09-28 17:51
Articles in Press	2015-09-28 17:51
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2015-11-28 20:19
Publish the Manuscript Online	2015-12-09 18:37

ISSN	2218-4333 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Oncology
Manuscript Type	Editorial
Article Title	Sentinel lymph node metastasis after neoadjuvant treatment in breast cancer: Any size matters?
Manuscript Source	Invited Manuscript
All Author List	Isabel T Rubio
Funding Agency and Grant Number
Corresponding Author	Isabel T Rubio, MD, PhD, Breast Surgical Oncology Unit, Breast Cancer Center, Hospital Universitario Vall d’Hebron, Universitat Autònoma de Barcelona, Paseo Vall d’Hebron 119, 08035 Barcelona, Spain. irubio@vhio.net
Key Words	Sentinel node; Metastasis; Neoadjuvant treatment; Breast cancer
Core Tip	One of the advantages of neoadjuvant chemo-therapy treatment in breast cancer is to downstage positive axillary nodes to negative. Postneoadjuvant sentinel lymph node (SLN) has been increasingly used and randomized studies in patients with positive axillary nodes who convert to node negative have shown that false negative rates are highly influenced by the surgical technique. Information from these studies has shown that isolated tumor cells in the SLN, when considered as positive nodes, lower false negative rates. Whether any residual disease in the SLNs may have prognostic implications warrants further research.
Publish Date	2015-12-09 18:37
Citation	Rubio IT. Sentinel lymph node metastasis after neoadjuvant treatment in breast cancer: Any size matters? World J Clin Oncol 2015; 6(6): 202-206
URL	http://www.wjgnet.com/2218-4333/full/v6/i6/202.htm
DOI	http://dx.doi.org/10.5306/wjco.v6.i6.202

Full Article (PDF)	WJCO-6-202.pdf
Full Article (Word)	WJCO-6-202.doc
Manuscript File	19912-Review.docx
Answering Reviewers	19912-Answering reviewers.pdf
Audio Core Tip	19912-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	19912-Conflict-of-interest statement.pdf
Copyright License Agreement	19912-Copyright assignment.pdf
Peer-review Report	19912-Peer-review(s).pdf
Scientific Misconduct Check	19912-Scientific misconduct check.pdf
Scientific Editor Work List	19912-Scientific editor work list.pdf